Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine butylbromide for first-stage labor pain and fetal heart rate in multiparous women
IRCT20180424039407N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hyoscine butylbromide in labor pain (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Pain severity of first stage of labor and Fetal heart rate. Started May 2018; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
labor pain
Beyond the preview
Go deeper on IRCT20180424039407N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180424039407N1.